Braze, Inc. (NASDAQ:BRZE) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On June 24, Oppenheimer lowered ...

Fintel reports that on July 16, 2025, Oppenheimer initiated coverage of MBX Biosciences (NasdaqGS:MBX) with a Outperform recommendation. Analyst Price Forecast Suggests 207.65% Upside As of June 20, ...

ODP, on May 7, reported quarterly earnings of $1.06 per share. It beat the analyst consensus estimate of 65 cents per share.

Coinbase Global is facing what analysts at Oppenheimer describe as an “unfavorable” setup heading into its second-quarter ...

Abbott Laboratories remains a top pick in volatile markets thanks to strong fundamentals and regulatory tailwinds.

Oppenheimer analyst Brian Schwartz issued a bullish outlook for Microsoft (NASDAQ: MSFT), raising its price target to $600—a ...